HBB rs121908250: Understanding Hemoglobin S-Antilles
The rs121908250 variant is a rare genetic change located within the HBB gene. It is associated with the production of Hemoglobin S-Antilles, a structural variant of beta-globin that can influence how hemoglobin binds and releases oxygen.
What each genotype means
Typical hemoglobin function
You carry two reference copies of this position in the HBB gene and do not have the Hemoglobin S-Antilles mutation. You are not at an increased risk for sickle cell complications specifically associated with this rare structural beta-globin alteration. Standard baseline health and carrier screening guidance continues to apply.
Carried by more than 99.9% of individuals across all major global populations.
Hb S-Antilles carrier state
You carry one copy of the Hemoglobin S-Antilles variant, which produces an altered beta-globin chain with decreased oxygen affinity and reduced solubility. Research shows that unlike standard sickle cell trait, individuals heterozygous for Hb S-Antilles can occasionally experience mild sickling manifestations or hemolytic anemia under conditions of low oxygen tension or physiological stress. Discussing this result with a hematologist or genetic counselor can help clarify its clinical context.
Extremely rare worldwide; primarily identified in small founder lineages of Afro-Caribbean ancestry.
Severe sickling phenotype
You carry two copies of the Hemoglobin S-Antilles mutation in the HBB gene. Homozygosity for this variant is expected to cause a severe form of sickle cell disease characterized by significant erythrocyte sickling, chronic hemolysis, and altered oxygen transport. You should review these findings with a hematologist or clinical genetics professional for comprehensive evaluation.
Virtually unobserved in general global cohorts, restricted to exceedingly rare familial pedigrees.
What is the rs121908250 Variant?
The rs121908250 variant is a specific change in the DNA sequence of the HBB gene. In genetics, a single nucleotide polymorphism (SNP) like this represents a variation at a single position in the genome. This particular variant is categorized as a structural mutation, meaning it alters the instructions for building the beta-globin protein, a critical component of hemoglobin. Hemoglobin is the protein in red blood cells responsible for carrying oxygen from the lungs to the rest of the body. When the HBB gene contains specific variants, the resulting hemoglobin protein may have different physical or chemical properties compared to the standard version. Researchers track these variants to understand how they impact the stability and function of red blood cells under various physiological conditions, such as low oxygen levels.
The Role of the HBB Gene
The HBB gene provides instructions for making a protein called beta-globin. This protein is a subunit of hemoglobin, the molecule that gives red blood cells their color and allows them to transport oxygen. Hemoglobin is typically composed of four subunits: two alpha-globin chains and two beta-globin chains. Because the HBB gene is essential for the proper formation of these chains, any significant change in its sequence can lead to the production of abnormal hemoglobin. While many variants in this gene are benign, others are associated with well-known conditions like sickle cell disease or beta-thalassemia. The HBB gene is located on chromosome 11 and is highly studied because of its central role in human health and its evolutionary history in regions where malaria is endemic.
Research and Clinical Associations
Scientific research identifies rs121908250 as the cause of Hemoglobin S-Antilles. Studies have shown that this variant results in hemoglobin with a significantly lower affinity for oxygen compared to normal hemoglobin. This means the hemoglobin releases oxygen more readily than expected. Furthermore, research indicates that this variant can exhibit reduced solubility, particularly in dense red blood cells. While the evidence linking this specific variant to clinical pathology is considered limited in scope, it is recognized as a structural hemoglobin variant. It is important to note that the presence of such a variant does not automatically result in a specific disease state for every individual. Clinical outcomes can be influenced by other genetic factors, environmental conditions, and the presence of other co-inherited hemoglobin variants.
Population Frequency and Distribution
The rs121908250 variant is extremely rare on a global scale. It is not found in the general population at high frequencies. Instead, it is primarily identified within specific, isolated founder lineages, particularly among populations with Afro-Caribbean ancestry. Because it is restricted to these specific groups, it is not a variant typically screened for in broad, population-wide genetic testing. The rarity of this variant means that large-scale data on its prevalence is sparse, and much of what is known comes from specialized studies of hemoglobinopathies in specific geographic or ethnic cohorts. Its distribution is a classic example of how rare genetic variants can persist within smaller, ancestral populations.
Understanding Your Genetic Information
If you have received information about this variant, it is important to understand that genetic data is complex and often requires professional interpretation. A variant being present does not necessarily mean you have a medical condition. Many people carry rare variants without experiencing any health issues. You cannot use this information to diagnose yourself or make medical decisions. If you are concerned about your hemoglobin levels or potential genetic conditions, the most appropriate step is to consult with a healthcare provider or a genetic counselor. They can provide context based on your personal health history and, if necessary, order clinical tests like hemoglobin electrophoresis to determine how your blood cells are functioning. Always discuss any health-related genetic findings with a qualified clinician.
How common is this variant?
The rs121908250 variant is very rare globally, with occurrences primarily documented in isolated founder lineages of Afro-Caribbean ancestry.
Frequently asked questions
What is Hemoglobin S-Antilles?
Hemoglobin S-Antilles is a specific, abnormal form of the hemoglobin protein caused by the rs121908250 variant. It is characterized by lower oxygen affinity and reduced solubility in red blood cells.
Is rs121908250 the same as sickle cell disease?
No, rs121908250 is a distinct variant. While it is a structural hemoglobin variant like the one that causes sickle cell disease, it is a different genetic change with its own specific biochemical properties.
Should I be worried if I have this variant?
The presence of a rare variant does not automatically mean you have a health problem. You should discuss any genetic findings with a doctor or genetic counselor who can interpret the results in the context of your overall health.
How is this variant detected?
This variant is typically identified through DNA sequencing. In a clinical setting, doctors might use hemoglobin electrophoresis or other blood tests to see how your hemoglobin is functioning.
Sources & further reading
Educational information only, last refreshed 10/11/2026. Not medical advice — these associations describe population statistics, not individual predictions.
Curious what your genotype is for rs121908250?
Upload a raw DNA file from 23andMe, AncestryDNA, MyHeritage, or FamilyTreeDNA and see this variant — plus thousands more — interpreted in your full report.
Get my report — $29Related variants in HBB
This variant is a pathogenic mutation in the HBB gene associated with beta-thalassemia.
This variant is a pathogenic mutation in the HBB gene associated with hemoglobinopathies such as sickle cell disease.
This variant (c.20A>T, p.Glu7Val) causes the substitution of valine for glutamic acid in the beta-globin chain, leading to sickle cell trait or disease depending on zygosity.
Pathogenic nonsense mutation (c.118C>T / p.Gln40Ter / codon 39 nonsense) causing beta-zero thalassemia and classic carrier status (beta-thalassemia minor).
This variant, known as Hb C-Harlem, involves a double mutation in the HBB gene that can lead to sickle-beta-thalassemia-like phenotypes.
A variant in the HBB gene linked to beta-thalassemia carrier status.